BBIO: BridgeBio Pharma, Inc. Stock

by  •  • Comments Off on BBIO: BridgeBio Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6,129.78
Enterprise Value ($M) 7,180.35
Book Value ($M) -1,457.61
Book Value / Share -7.66
Price / Book -4.21
NCAV ($M) -1,656.26
NCAV / Share -8.71
Price / NCAV -3.70

Profitability (mra)
Return on Invested Capital (ROIC) -1.93
Return on Assets (ROA) -0.98
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.33
Current Ratio 5.33

Balance Sheet (mrq) ($M)
Current Assets 720.69
Assets 919.34
Liabilities 2,376.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 221.90
Operating Income -577.37
Net Income -535.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -520.73
Cash from Investing 60.78
Cash from Financing 748.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13D/A KKR Genetic Disorder L.P. 10.10 -23.75
02-13 13G/A Kumar Neil 5.41 5.09
01-31 13D/A Viking Global Investors Lp 11.70 -12.20
11-12 13G/A BlackRock, Inc. 6.80 0.00
2024-02-13 13G/A Vanguard Group Inc 7.36 20.85

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 789,879 2,663,189 29.66
2025-03-06 1,236,523 5,073,162 24.37
2025-03-05 461,388 1,826,893 25.26
2025-03-04 781,077 2,226,273 35.08

(click for more detail)

Similar Companies
ATRA – Atara Biotherapeutics, Inc. AVIR – Atea Pharmaceuticals, Inc.
AVXL – Anavex Life Sciences Corp. BCRX – BioCryst Pharmaceuticals, Inc.
BDTX – Black Diamond Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io